RNA Manufacturing Videos
-
Meet Dr. Zoltán Kis And The Wellcome Leap RNA R3 Program
5/22/2023
In this segment from the Surge Manufacturing for Biopharma Resilience live event, University of Sheffield’s Dr. Zoltán Kis shares the work he’s doing on the Wellcome Leap RNA R3 program.
-
Pioneers And Visionaries Of Nucleic Acid And Nanoparticle-Based Therapeutics
12/12/2024
Explore the future of nucleic acid and nanoparticle-based therapeutics, including mRNA, CRISPR, and gene editing, as experts discuss innovative solutions for complex health challenges.
-
Novel Excipients Versus Active Substances And Inflammatory Response
10/16/2023
Novel excipients or active substances? In this segment of Risk Reduction In mRNA Therapeutic Development, we address the debate and discuss LNP-related inflammatory response concerns.
-
Accelerate Genomic Medicine Innovations
4/13/2022
Once you know what disease gene you want to target, you can very rapidly find the sequence of the molecule you want to use as the drug substance, and essentially print it out, go to a supplier or print it out on a machine.
-
Millipore Sigma Bio-Expo Live June 2025: Downstream Bioprocessing
7/3/2025
Learn about the development and advantages of a new affinity ligand platform. It provides versatile, single-step purification for recombinant proteins and virus particles, enhancing yield and purity.
-
Small-Scale Oligonucleotide Synthesizer That Supports Scale Up
2/16/2023
Learn about a small oligonucleotide synthesizer with big impact that features a user-friendly interface, compact footprint, and more. This small scale system is user friendly and supports scale up.
-
Quality Concepts In GMP IVT mRNA Development, Manufacturing, And Analytics
2/13/2025
Stay ahead in mRNA therapeutic development by mastering the essential quality systems, process controls, and analytical methods required for robust GMP production and efficient manufacturing.
-
Is QbD Actually Possible In mRNA Development Today?
8/22/2024
As the panelists of this Advancing RNA LIVE discussion argue, there are several big limitations we face in implementing QBD today for RNA development.
-
MilliporeSigma Bio-Expo Live February 2025: Downstream Bioprocessing
3/17/2025
Advancements in single-use technologies are transforming antibody-drug conjugate manufacturing and offering increased flexibility. Examine key data, design considerations, operational benefits, and applications in ADC production.
-
How "Successful" Are Our mRNA-LNP Outsourcing Partnerships Today?
2/10/2025
In this snippet, panelist Alex Aust (with the help of several live attendee commenters) tackles a particularly tricky question: Are our outsourcing partnerships producing high quality products today, and what are the most common root causes of batch failures?